CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST

By In The News
July 10, 2019 in The Headlines

Recommended Posts

In The News

Posted July 10, 2019

- Share

Posted July 10, 2019

SUZHOU, China, July 9, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient has been dosed in China with avapritinib in the ongoing global Phase III VOYAGER clinical trial. This study is designed to evaluate the safety and efficacy of...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  221942
2. Jaydee
  17737
3. deicer
  13302
4. Kip Powick
  12305
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.3k
- Total Posts
  
  564.8k

Sign In

CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support